Annual Shareholders Equity
$11.37 M
+$113.52 M+111.13%
December 31, 2023
Summary
- As of February 8, 2025, ELTX annual stockholders equity is $11.37 million, with the most recent change of +$113.52 million (+111.13%) on December 31, 2023.
- During the last 3 years, ELTX annual shareholders equity has risen by +$60.51 million (+123.14%).
- ELTX annual shareholders equity is now at all-time high.
Performance
ELTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$18.99 M
-$17.33 M-1049.27%
September 30, 2024
Summary
- As of February 8, 2025, ELTX quarterly stockholders equity is -$18.99 million, with the most recent change of -$17.33 million (-1049.27%) on September 30, 2024.
- Over the past year, ELTX quarterly shareholders equity has dropped by -$32.27 million (-242.90%).
- ELTX quarterly shareholders equity is now -180.60% below its all-time high of $23.56 million, reached on June 30, 2023.
Performance
ELTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ELTX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +111.1% | -242.9% |
| 3 y3 years | +123.1% | - |
| 5 y5 years | +132.6% | - |
ELTX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +111.1% | -180.6% | +81.4% |
| 5 y | 5-year | at high | +111.1% | -180.6% | +81.4% |
| alltime | all time | at high | +111.1% | -180.6% | +81.4% |
Elicio Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$18.99 M(+1049.3%) |
| Jun 2024 | - | -$1.65 M(-133.9%) |
| Mar 2024 | - | $4.87 M(-57.2%) |
| Dec 2023 | $11.37 M | $11.37 M(-14.4%) |
| Sep 2023 | - | $13.29 M(-43.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $23.56 M(-123.1%) |
| Dec 2022 | -$102.14 M(+37.0%) | -$102.14 M(+86.2%) |
| Dec 2021 | -$74.54 M(+51.7%) | - |
| Mar 2021 | - | -$54.87 M |
| Dec 2020 | -$49.14 M(+40.8%) | - |
| Dec 2019 | -$34.90 M | - |
FAQ
- What is Elicio Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Elicio Therapeutics?
- What is Elicio Therapeutics annual shareholders equity year-on-year change?
- What is Elicio Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Elicio Therapeutics?
- What is Elicio Therapeutics quarterly shareholders equity year-on-year change?
What is Elicio Therapeutics annual stockholders equity?
The current annual shareholders equity of ELTX is $11.37 M
What is the all time high annual shareholders equity for Elicio Therapeutics?
Elicio Therapeutics all-time high annual stockholders equity is $11.37 M
What is Elicio Therapeutics annual shareholders equity year-on-year change?
Over the past year, ELTX annual stockholders equity has changed by +$113.52 M (+111.13%)
What is Elicio Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ELTX is -$18.99 M
What is the all time high quarterly shareholders equity for Elicio Therapeutics?
Elicio Therapeutics all-time high quarterly stockholders equity is $23.56 M
What is Elicio Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ELTX quarterly stockholders equity has changed by -$32.27 M (-242.90%)